|
MED7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
9.41359999950819E-08 |
| Normal-vs-Stage3 |
5.6665783176868E-13 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
5.748400E-01 |
| Stage1-vs-Stage3 |
5.207600E-01 |
| Stage1-vs-Stage4 |
2.902400E-03 |
| Stage2-vs-Stage3 |
3.986800E-01 |
| Stage2-vs-Stage4 |
1.102010E-02 |
| Stage3-vs-Stage4 |
2.078500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.47280000031935E-07 |
| Normal-vs-Asian |
3.6680003479006E-10 |
| Caucasian-vs-AfricanAmerican |
7.360800E-01 |
| Caucasian-vs-Asian |
7.025000E-01 |
| AfricanAmerican-vs-Asian |
5.822800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.77315972805081E-15 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
7.122400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
4.7750692289128E-13 |
| Normal-vs-Age(61-80Yrs) |
1.63158375698913E-12 |
| Normal-vs-Age(81-100Yrs) |
3.255000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.498600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.397760E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.827200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.841420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.983000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.712800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.160800E-04 |
| Classical-VS-Follicular |
8.525000E-01 |
| Classical-VS-Other |
3.103200E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
2.516000E-03 |
| Tall-VS-Other |
7.236000E-01 |
| Tall-VS-Normal |
2.99760216648792E-15 |
| Follicular-VS-Other |
3.787000E-01 |
| Follicular-VS-Normal |
7.47619965935087E-10 |
| Other-VS-Normal |
1.645600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.91273688396632E-13 |
| Normal-vs-N1 |
2.55351295663786E-15 |
| N0-vs-N1 |
4.064300E-03 |
|
|
